BLRX

BioLineRX

18 hedge funds and large institutions have $16.7M invested in BioLineRX in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
7
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$4.2M 2,021,347 +118,547 +6%
SM
2
Senvest Management
New York
$3.31M 1,591,367 +41,562 +3%
BI
3
BVF Inc
California
$3.12M 1,501,000 +701,000 +88%
O
4
OrbiMed
New York
$2.36M 1,135,000
OM
5
Opaleye Management
Massachusetts
$1.35M 650,000 -801,000 -55%
SFM
6
Sphera Funds Management
Israel
$1.25M 600,000
Deutsche Bank
7
Deutsche Bank
Germany
$399K 191,850 -31,200 -14%
PA
8
Perceptive Advisors
New York
$345K 165,698 -13,343 -7%
Renaissance Technologies
9
Renaissance Technologies
New York
$91K 43,700 +16,900 +63%
BCA
10
Benchmark Capital Advisors
New York
$83K 40,000 +20,000 +100%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$37K 17,800
NFG
12
Next Financial Group
Texas
$30K 17,500 +17,500 New
VKH
13
Virtu KCG Holdings
New York
$25K 11,962 -6,678 -36%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$25K 12,000
Morgan Stanley
15
Morgan Stanley
New York
$21K 10,275 +884 +9%
U
16
UBS
Switzerland
$21K 10,000 +7,033 +237%
Wells Fargo
17
Wells Fargo
California
$2K 1,000
Ameriprise
18
Ameriprise
Minnesota
$1K 310 +310 New
Jane Street
19
Jane Street
New York
-59,063 Closed
Citadel Advisors
20
Citadel Advisors
Florida
-32,373 Closed
Citigroup
21
Citigroup
New York
-826 Closed